Reaction

Lobar Pneumonia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,853 reports · 67 co-occurring drugs

As of the last recalculation, Lobar Pneumonia appears in 1,853 FAERS reports alongside 67 co-occurring drug terms. The strongest observed disproportionality signal is THEOPHYLLINE (PRR 16.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Theophylline	17	16.8	16.8
Theophylline Anhydrous	17	15.5	15.6
Nystatin Ointment	34	14.8	14.8
Nystatin Cream	34	14.8	14.8
Standardized Senna Concentrate	16	14.4	14.4
Nystatin	34	14.2	14.2
Dronabinol	10	14.0	14.1
Temozolomide	25	13.5	13.5
Alendronate Sodium	114	13.5	13.5
Bumetanide	30	13.0	13.0
Etonogestrel And Ethinyl Estradiol	25	12.8	12.8
Ipratropium Bromide	39	12.5	12.5
Captopril	10	11.7	11.8
Diltiazem Hydrochloride	35	11.6	11.6
Chlorhexidine Gluconate	9	11.1	11.1
Digoxin	68	11.0	11.0
Cefuroxime	11	10.9	10.9
Acetylcysteine	9	10.8	10.8
Docusate Sodium - Sennosides	30	10.6	10.6
Erythropoietin	19	10.5	10.5
Salmeterol Xinafoate	8	10.5	10.5
Warfarin Sodium	41	10.1	10.1
Gefitinib	8	10.0	10.0
Fondaparinux Sodium	7	9.7	9.8
Gemfibrozil	13	9.7	9.7
Epoetin Alfa	10	9.5	9.5
Calcium Gluconate	10	9.4	9.4
Thalidomide	30	9.3	9.3
Nitroglycerin	43	9.2	9.2
Timolol Maleate	8	9.1	9.1
Cisplatin	61	9.0	9.0
Nicotine Polacrilex Mini	12	9.0	9.0
Nicotine Polarilex	12	9.0	9.0
Cefepime	11	8.7	8.7
Cefepime Hydrochloride	12	8.4	8.4
Lopinavir And Ritonavir	10	8.3	8.3
Enoxaparin Sodium	41	8.2	8.2
Metolazone	8	8.0	8.0
Insulin Human	28	8.0	8.0
Vincristine Sulfate	20	7.7	7.7
Bendamustine Hydrochloride	8	7.5	7.5
Guaifenesin	20	7.4	7.4
Prochlorperazine Maleate	6	7.3	7.3
Melphalan Hydrochloride	16	7.2	7.2
Human Insulin	8	7.2	7.2
Bortezomib	53	6.8	6.8
Bicalutamide	9	6.7	6.7
Doxorubicin Hydrochloride	17	5.9	5.9
Fluticasone Propionate And Salmeterol	21	5.7	5.7
Loratadine And Pseudoephedrine Sulfate	4	5.7	5.7
Oseltamivir	4	5.7	5.7
Tiotropium Bromide	66	5.6	5.6
Etoposide	35	5.4	5.4
Miconazole Nitrate	4	5.2	5.2
Deferasirox	12	5.1	5.1
Lapatinib	7	5.1	5.1
Oseltamivir Phosphate	10	4.6	4.6
Azacitidine	12	4.6	4.6
Erlotinib Hydrochloride	5	4.5	4.5
Darbepoetin Alfa	21	4.4	4.4
Drospirenone And Ethinyl Estradiol	15	3.8	3.8
Hydrocodone Bitartrate	14	3.6	3.6
Cetuximab	10	3.6	3.6
Dabigatran Etexilate Mesylate	22	3.4	3.4
Dasatinib	10	3.0	3.0
Palivizumab	4	2.9	2.9
Lenalidomide	88	2.4	2.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.